Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC284600 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAPOLA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SUMO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREBZF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHCYL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDRG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBLN3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL13B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM92A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM221A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POC1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IREB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESCO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on